Antibiotics for acute pyelonephritis in children (Q24244919)

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

Urinary tract infections with tissue penetration in children: cefotaxime compared with amoxycillin/clavulanate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelonephritis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

Comparative study of cefixime alone versus intramuscular ceftizoxime followed by cefixime in the treatment of urinary tract infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

Single or multiple daily doses of aminoglycosides: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

The hazards of scoring the quality of clinical trials for meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Survey of the attitudes to management of acute pyelonephritis in children. GEP

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Attitude of Belgian pediatricians toward strategy in acute pyelonephritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Primary vesicoureteral reflux: review of current concepts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Treatment of children with acute pyelonephritis: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Three-day antimicrobial therapy of urinary tract infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Renal damage one year after first urinary tract infection: role of dimercaptosuccinic acid scintigraphy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Urinary tract infections. Old and new concepts.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Controlled trial of co-trimoxazole in children with urinary-tract infection. Bacteriological efficacy and haematological toxicity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Isepamicin versus amikacin for the treatment of acute pyelonephritis in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Risk factors for recurrent urinary tract infection in preschool children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Short-course versus conventional length antimicrobial therapy for uncomplicated lower urinary tract infections in children: a meta-analysis of 1279 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Single-dose cefotaxime in the treatment of urinary tract infections in children: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Recurrent urinary tract infections in children.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Once daily cefixime compared with twice daily trimethoprim/sulfamethoxazole for treatment of urinary tract infection in infants and children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Cefepine vs. ceftazidime treatment of pyelonephritis: a European, randomized, controlled study of 300 pediatric cases. European Society for Paediatric Infectious Diseases (ESPID) Pyelonephritis Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

The value of level diagnosis of childhood urinary tract infection in predicting renal injury

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

The length of antimicrobial therapy in upper vs. lower urinary tract infection of childhood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Single dose trimethoprim-sulphamethoxazole treatment of symptomatic urinary infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Association between urinary symptoms at 7 years old and previous urinary tract infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Renal scarring after acute pyelonephritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Short compared with standard duration of antibiotic treatment for urinary tract infection: a systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Development of new renal scars: a collaborative study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

The Comparative Efficacy of Cephalexin and Sulfisoxazole in Acute Urinary Tract Infection in Children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Effectiveness of cefetamet pivoxil in the treatment of pyelonephritis in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Comparison of ceftriaxone versus cefotaxime for childhood upper urinary tract infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

Oral versus initial intravenous therapy for urinary tract infections in young febrile children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021

A meta-analysis of randomized, controlled trials comparing short- and long-course antibiotic therapy for urinary tract infections in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003772.PUB2

7 January 2021